The Effect of Pretreatment with the Hydroalcoholic Extract of Ginger on the Modulation of Dopamine D2 Receptor Agonist and Antagonist Impacts on Pain Sensitivity in Male Rats

  • Mohammad Hossein Faraji 1- Physiology Division, Department of Basic Science, School of Veterinary Medicine, Shiraz University, Shiraz, Iran
  • Mahnaz Taherianfard * Shiraz University
Keywords: Ginger, Dopamin D2 receptor, Pain, Male Rat

Abstract

Background and Aim: Zingiber officinale (ginger) extract increased dopamine concentration in various brain areas. Therefore, the present study aimed to investigate how ginger extract can affect the efficiency of D2 receptor agonist (bromocriptine) and antagonist (chlorpromazine) on pain sensitivity in rats. Materials and Methods: Forty-eight adult male rats in standard conditions divided into eight groups, i.e. the control, the ginger sham1, sham2, ginger, bromocriptine 10 or 30 µM + ginger, and chlorpromazine 20 or 40 µM + ginger. The cannulation of the lateral ventricle was conducted unilaterally by the stereotaxic procedure. A pain sensitivity test was carried out in all the groups by formalin test on the 16th day. Results: The results of this study indicated that ginger could remarkablly (P<0.01) reduce pain sensitivity in all stages of the formalin test. As the data revealed, bromocriptine 10 or 30 µg/rat and chlorpromazine 20 or 40 µg/rat significantly (P<0.01) decreased the pain sensitivity in all phases of the formalin test in comparison with the control and sham groups. However, chlorpromazine 20 or 40 µg/rat noticeably (P<0.01) increased the pain sensitivity when compared to ginger and bromocriptine groups. Conclusion: According to the results of the present study, ginger mimics the analgesic effect of bromocriptine. Moreover, ginger has attenuated the hyperalgesic effect of chlorpromazine. It seems that ginger has a synergistic effect with the analgesic effect of the dopamine D2 receptor.

References

Alcock MM. Defining pain: past, present, and future. Pain. 2017;158(4):761-2.

Baron R, Maier C, Attal N, Binder A, Bouhassira D, Cruccu G, et al. Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles. Pain. 2017;158(2):261-72.

Taylor AM, Becker S, Schweinhardt P, Cahill C. Mesolimbic dopamine signaling in acute and chronic pain: implications for motivation, analgesia, and addiction. Pain. 2016;157(6):1194-8.

Jarcho JM, Mayer EA, Jiang ZK, Feier NA, London ED. Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction. Pain. 2012;153(4):744-54.

Treister R, Pud D, Eisenberg E. The dopamine agonist apomorphine enhances conditioned pain modulation in healthy humans. Neurosci Lett. 2013;548:115-9.

Rahnama P, Montazeri A, Huseini HF, Kianbakht S, Naseri M. Effect of Zingiber officinale R. rhizomes (ginger) on pain relief in primary dysmenorrhea: a placebo randomized trial. BMC Complement Altern Med. 2012;12:92.

Rayati F, Hajmanouchehri F, Najafi E. Comparison of anti-inflammatory and analgesic effects of Ginger powder and Ibuprofen in postsurgical pain model: A randomized, double-blind, case-control clinical trial. Dent Res J (Isfahan). 2017;14(1):1-7.

Park G, Kim HG, Ju MS, Ha SK, Park Y, Kim SY, et al. 6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson's disease models via anti-neuroinflammation. Acta Pharmacol Sin. 2013;34(9):1131-9.

Sundaresan P, Chen YC, Chen SM, Chen TW, Latha P, Lou BS. Novel ginger-like morphology of barium molybdate: A promising electrocatalyst for the detection of neurotransmitter dopamine. Int J Electrochem Sci. 2018;13:10809–20.

Taherianfard M, Farhangdareshuri F, Shomali T. Interactive effect of aqueous-alcoholic extract of ginger as well as GABAA receptor agonist and antagonist on pain sensitivity in male rats. Physiol Pharmacol 2018;22:247-53.

Paxinos G, Watson C. The rat brian in stereotaxic coordinates. Third edn. Paul Haltasz & Lewis Tsalls: Sydney2004.

Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev. 2001;53(4):597-652.

Mohd Sahardi NFN, Makpol S. Ginger (Zingiber officinale Roscoe) in the Prevention of Ageing and Degenerative Diseases: Review of Current Evidence. Evid Based Complement Alternat Med. 2019;2019:5054395.

Rondanelli M, Riva A, Morazzoni P, Allegrini P, Faliva MA, Naso M, et al. The effect and safety of highly standardized Ginger (Zingiber officinale) and Echinacea (Echinacea angustifolia) extract supplementation on inflammation and chronic pain in NSAIDs poor responders. A pilot study in subjects with knee arthrosis. Nat Prod Res. 2017;31(11):1309-13.

Moradi M, Yazdanian M, Haghparast A. Role of dopamine D2-like receptors within the ventral tegmental area and nucleus accumbens in antinociception induced by lateral hypothalamus stimulation. Behav Brain Res. 2015;292:508-14.

Asami A, Shimada T, Mizuhara Y, Asano T, Takeda S, Aburada T, et al. Pharmacokinetics of [6]-shogaol, a pungent ingredient of Zingiber officinale Roscoe (Part I). J Nat Med. 2010;64(3):281-7.

Li C, Liu S, Lu X, Tao F. Role of Descending Dopaminergic Pathways in Pain Modulation. Curr Neuropharmacol. 2019;17(12):1176-82.

Hagelberg N, Jaaskelainen SK, Martikainen IK, Mansikka H, Forssell H, Scheinin H, et al. Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur J Pharmacol. 2004;500(1-3):187-92.

Fajrin FA, Nugroho AE, Nurrochmad A, Susilowati R. Ginger extract and its compound, 6-shogaol, attenuates painful diabetic neuropathy in mice via reducing TRPV1 and NMDAR2B expressions in the spinal cord. J Ethnopharmacol. 2020;249:112396.

Moradi M, Yazdian MR, Haghparast A. Lateral hypothalamus chemical stimulation-induced antinociception was attenuated by injection of dopamine D1 and D2 receptor antagonists in the ventral tegmental area. Physiology and Pharmacology. 2014;18(1):36-46.

Oláh Z, Jósvay K, Pecze L, Letoha T, Babai N, Budai D, et al. Anti-calmodulins and Tricyclic Adjuvants in Pain Therapy Block the TRPV1 Channel. PLoS One. 2007;2(6):e545.

Wood PB. Role of central dopamine in pain and analgesia. Expert Rev Neurother. 2008;8(5):781-97.

Published
2022-07-11
Section
Original Article